Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

By Tateyama Masakuni   Yatsuhashi Hiroshi   Taura Naota   Motoyoshi Yasuhide   Nagaoka Shinya   Yanagi Kenji   Abiru Seigo   Yano Koji   Komori Atsumasa   Migita Kiyoshi   Nakamura Minoru   Nagahama Hiroyasu   Sasaki Yutaka   Miyakawa Yuzo   Ishibashi Hiromi  

Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 92-100

Springer Publishing Company

Access to resources Recommend Favorite

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment

By Mamori Satoshi   Suzuki Fumitaka   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 776-782

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase Levels

By  

Digestion, Vol. 65, Iss. 2, 2002-05 ,pp. : 127-130

Karger

Access to resources Recommend Favorite

High levels of serum antibodies to cell surface proteins of Helicobacter pullorum and Helicobacter pylori in hepatitis C virus-infected patients

By Lonngren Vincent   Nilsson Ingrid   Verbaan Hans   Wadstrom Torkel   Ljungh Åsa  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 4, 2009-04 ,pp. : 505-506

Informa Healthcare

Access to resources Recommend Favorite

Perspectives for a hepatitis C virus vaccine

By Abrignani S.   Rosa D.  

Clinical and Diagnostic Virology, Vol. 10, Iss. 2, 1998-07 ,pp. : 181-185

Elsevier

Access to resources Recommend Favorite